Keywords: Eisai, Netherlands, Zonegran, Epilepsy

Eisai opens for business in the Netherlands, with Zonegran the first product

Article | 14 January 2011

Print This

Eisai Europe, a subsidiary of Japanese drug major Eisai (TYO: 4532), has set up a sales and marketing operation in its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in